longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

GENSCRIPT BIO

01548

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -14.79, within the reasonable range, cheaper than 33% of the time in the past 5 years, and the industry ranks 13/15, the industry Median 14.61.

-14.79xP/E
HK$32.38Stock price
HK$-2.19Earnings per share
-14.79xP/E
Stock priceHK$32.38Earnings per shareHK$-2.19

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-18.71x
Typical range
-31.25x–0.95x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 14.61x
014284256

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 14.61x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
01548HKGENSCRIPT BIO
-14.79x95.10%HK$73.84B
02228HKXTALPI
-122.68x130.90%HK$29.80B
03696HKINSILICO
-12.65x100.52%HK$29.51B
02576HKTAIMEI TECH
-36.37x--HK$2.73B
08225HKC HEALTH GP
-4.88x--HK$79.63M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.